Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Nasal congestion, Nasopharyngitis, Throat irritation
Clinical narrative: stuffy nose/one nostril not totally clear; throat a little scratchy; can't tell if that if my taste is off or not; cold; This spontaneous case was reported by a patient and describes the occurrence of NASAL CONGESTION (stuffy nose/one nostril not totally clear), THROAT IRRITATION (throat a little scratchy), AGEUSIA (can't tell if that if my taste is off or not) and NASOPHARYNGITIS (cold) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.  Concomitant products included INFLUENZA VACCINE (FLU VACCINE VII) for an unknown indication.   On 27-Jul-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (stuffy nose/one nostril not totally clear), THROAT IRRITATION (throat a little scratchy), AGEUSIA (can't tell if that if my taste is off or not) and NASOPHARYNGITIS (cold). At the time of the report, NASAL CONGESTION (stuffy nose/one nostril not totally clear), THROAT IRRITATION (throat a little scratchy), AGEUSIA (can't tell if that if my taste is off or not) and NASOPHARYNGITIS (cold) outcome was unknown.            Patient received two primary series doses and two boosters, all Moderna. No treatment information was reported.  Patient had  a lot of Things all the time.  Company comment: This spontaneous case concerns an 86-year-old patient of an unknown gender, with no reported medical history, who experienced the unexpected non-serious AESI of Ageusia on unknown date in the context of receiving the 4th dose of mRNA-1273 vaccine (as 2nd booster) along with the other non-serious events of nasal congestion, throat irritation, and nasopharyngitis. Onset latency could not be determined as onset date of event was not provided. Patient reported stuffy nose, scratchy throat and "taste was off" which happened all the time. As reported, patient did not have COVID. Clinical course and treatment details were not reported. The outcome of event was reported as unknown. On unknown dates, patient had received 2-dose primary series and 1st booster of mRNA-1273 vaccine. Patient also received Flu vaccine approximately 3 months after the 4th dose of mRNA-1273 vaccine. It was reported that, patient was inquiring if she can take the bivalent booster dose if those reported symptoms were present. The benefit-risk relationship of mRNA-1273 is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns an 86-year-old patient of an unknown gender, with no reported medical history, who experienced the unexpected non-serious AESI of Ageusia on unknown date in the context of receiving the 4th dose of mRNA-1273 vaccine (as 2nd booster) along with the other non-serious events of nasal congestion, throat irritation, and nasopharyngitis. Onset latency could not be determined as onset date of event was not provided. Patient reported stuffy nose, scratchy throat and "taste was off" which happened all the time. As reported, patient did not have COVID. Clinical course and treatment details were not reported. The outcome of event was reported as unknown. On unknown dates, patient had received 2-dose primary series and 1st booster of mRNA-1273 vaccine. Patient also received Flu vaccine approximately 3 months after the 4th dose of mRNA-1273 vaccine. It was reported that, patient was inquiring if she can take the bivalent booster dose if those reported symptoms  were present. The benefit-risk relationship of mRNA-1273 is not affected by this report.